Clinical Trial Update: A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating the effect of vildagliptin on postprandial lipid parameters in patients with Type 2 di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED